{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:01:45Z","timestamp":1793138505852,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006212","name":"Hellenic Cardiological Society","doi-asserted-by":"publisher","award":["HCS2002"],"award-info":[{"award-number":["HCS2002"]}],"id":[{"id":"10.13039\/501100006212","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010353","name":"Hellenic Atherosclerosis Society","doi-asserted-by":"publisher","award":["HAS2003"],"award-info":[{"award-number":["HAS2003"]}],"id":[{"id":"10.13039\/501100010353","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.metabol.2021.154893","type":"journal-article","created":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T13:13:39Z","timestamp":1633007619000},"page":"154893","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"special_numbering":"C","title":["The presence of NAFLD influences the transition of metabolically healthy to metabolically unhealthy obesity and the ten-year cardiovascular disease risk: A population-based cohort study"],"prefix":"10.1016","volume":"128","author":[{"given":"Matina","family":"Kouvari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Chrysohoou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Skoumas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Pitsavos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Demosthenes B.","family":"Panagiotakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos S.","family":"Mantzoros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2021.154893_bb0005","doi-asserted-by":"crossref","first-page":"e277","DOI":"10.1016\/S2468-2667(17)30074-9","article-title":"Overweight, obesity, and risk of cardiometabolic multimorbidity: pooled analysis of individual-level data for 120,813 adults from 16 cohort studies from the USA and Europe","volume":"2","author":"Kivim\u00e4ki","year":"2017","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.metabol.2021.154893_bb0010","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.metabol.2015.10.019","article-title":"Metabolic health and weight: understanding metabolically unhealthy normal weight or metabolically healthy obese patients","volume":"65","author":"Mathew","year":"2016","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2021.154893_bb0015","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s13679-020-00375-0","article-title":"Metabolically healthy obesity: criteria, epidemiology, controversies, and consequences","volume":"9","author":"Tsatsoulis","year":"2020","journal-title":"Curr Obes Rep"},{"key":"10.1016\/j.metabol.2021.154893_bb0020","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1177\/2047487315623884","article-title":"Metabolically healthy obesity and cardiovascular events: a systematic review and meta-analysis","volume":"23","author":"Eckel","year":"2016","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.metabol.2021.154893_bb0025","doi-asserted-by":"crossref","first-page":"4761","DOI":"10.1016\/j.ijcard.2013.07.230","article-title":"Combined effect of obesity and cardio-metabolic abnormality on the risk of cardiovascular disease: a meta-analysis of prospective cohort studies","volume":"168","author":"Fan","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.metabol.2021.154893_bb0030","doi-asserted-by":"crossref","first-page":"758","DOI":"10.7326\/0003-4819-159-11-201312030-00008","article-title":"Are metabolically healthy overweight and obesity benign conditions?: a systematic review and meta-analysis","volume":"159","author":"Kramer","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.metabol.2021.154893_bb0035","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1136\/jech-2015-206948","article-title":"The long-term prognosis of cardiovascular disease and all-cause mortality for metabolically healthy obesity: a systematic review and meta-analysis","volume":"70","author":"Zheng","year":"2016","journal-title":"J Epidemiol Community Health"},{"key":"10.1016\/j.metabol.2021.154893_bb0040","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.metabol.2019.01.003","article-title":"Transition from metabolically benign to metabolically unhealthy obesity and 10-year cardiovascular disease incidence: the ATTICA cohort study","volume":"93","author":"Kouvari","year":"2019","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2021.154893_bb0045","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/j.jacc.2018.02.055","article-title":"Metabolically healthy obesity, transition to metabolic syndrome, and cardiovascular risk","volume":"71","author":"Mongraw-Chaffin","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.metabol.2021.154893_bb0050","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1007\/s00125-020-05116-5","article-title":"Transition of metabolic phenotypes and risk of subclinical atherosclerosis according to BMI: a prospective study","volume":"63","author":"Lin","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2021.154893_bb0055","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.dld.2014.09.020","article-title":"Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome","volume":"47","author":"Lonardo","year":"2015","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.metabol.2021.154893_bb0060","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S2213-8587(13)70062-7","article-title":"Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications","volume":"1","author":"Stefan","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.metabol.2021.154893_bb0065","doi-asserted-by":"crossref","DOI":"10.1111\/dom.14322","article-title":"Nonalcoholic fatty liver disease as a metabolic disease in humans: a literature review","author":"Cariou","year":"2021","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.metabol.2021.154893_bb0070","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/ajg.2016.178","article-title":"Metabolically healthy obesity and the development of nonalcoholic fatty liver disease","volume":"111","author":"Chang","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.metabol.2021.154893_bb0075","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1111\/liv.14184","article-title":"Metabolically healthy versus unhealthy obesity and risk of fibrosis progression in non-alcoholic fatty liver disease","volume":"39","author":"Kim","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.metabol.2021.154893_bb0080","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.diabet.2017.02.007","article-title":"Less liver fibrosis in metabolically healthy compared with metabolically unhealthy obese patients with non-alcoholic fatty liver disease","volume":"43","author":"Guti\u00e9rrez-Grobe","year":"2017","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.metabol.2021.154893_bb0085","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.numecd.2013.07.005","article-title":"Metabolically healthy obese subjects are at risk of fatty liver but not of pre-clinical atherosclerosis","volume":"24","author":"Sung","year":"2014","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.metabol.2021.154893_bb0090","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1471-2458-3-32","article-title":"Epidemiology of cardiovascular risk factors in Greece: aims, design and baseline characteristics of the ATTICA study","volume":"3","author":"Pitsavos","year":"2003","journal-title":"BMC Public Health"},{"key":"10.1016\/j.metabol.2021.154893_bb0095","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1161\/CIRCRESAHA.115.306883","article-title":"Obesity and cardiovascular disease","volume":"118","author":"Ortega","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.metabol.2021.154893_bb0100","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/j.jacc.2018.08.1037","article-title":"Healthy weight and obesity prevention: JACC health promotion series","volume":"72","author":"Lavie","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.metabol.2021.154893_bb0105","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1053\/j.gastro.2018.12.036","article-title":"Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease","volume":"156","author":"Castera","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.metabol.2021.154893_bb0110","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S2213-8587(14)70032-4","article-title":"Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome","volume":"2","author":"Yki-J\u00e4rvinen","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.metabol.2021.154893_bb0115","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1530\/EJE-15-0449","article-title":"Stability of metabolically healthy obesity over 8\u202fyears: the English Longitudinal Study of Ageing","volume":"173","author":"Hamer","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.metabol.2021.154893_bb0120","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/ijo.2016.179","article-title":"Metabolic phenotypes of obesity: frequency, correlates and change over time in a cohort of postmenopausal women","volume":"41","author":"Kabat","year":"2017","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.metabol.2021.154893_bb0125","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/S2213-8587(18)30137-2","article-title":"Transition from metabolic healthy to unhealthy phenotypes and association with cardiovascular disease risk across BMI categories in 90,257 women (the Nurses\u2019 Health Study): 30-year follow-up from a prospective cohort study","volume":"6","author":"Eckel","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.metabol.2021.154893_bb0130","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1038\/ijo.2015.75","article-title":"Visceral abdominal fat accumulation predicts the conversion of metabolically healthy obese subjects to an unhealthy phenotype","volume":"39","author":"Hwang","year":"2015","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.metabol.2021.154893_bb0135","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1002\/oby.22536","article-title":"Association between nonalcoholic fatty liver disease and future deterioration of metabolic health: a cohort study","volume":"27","author":"Hwang","year":"2019","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.metabol.2021.154893_bb0140","doi-asserted-by":"crossref","first-page":"372","DOI":"10.2337\/dc17-1902","article-title":"Nonalcoholic fatty liver disease and risk of incident type 2 diabetes: a meta-analysis","volume":"41","author":"Mantovani","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2021.154893_bb0145","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/eurheartj\/ehx448","article-title":"Separate and combined associations of obesity and metabolic health with coronary heart disease: a pan-European case-cohort analysis","volume":"39","author":"Lassale","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.metabol.2021.154893_bb0150","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/eurheartj\/ehu123","article-title":"Metabolically healthy obesity and the risk of cardiovascular disease and type 2 diabetes: the Whitehall II cohort study","volume":"36","author":"Hinnouho","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.metabol.2021.154893_bb0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0202666","article-title":"Non-alcoholic fatty liver disease is a strong predictor of coronary artery calcification in metabolically healthy subjects: a cross-sectional, population-based study in middle-aged subjects","volume":"13","author":"Gummesson","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2021.154893_bb0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0224626","article-title":"Nonalcoholic fatty liver disease is an early predictor of metabolic diseases in a metabolically healthy population","volume":"14","author":"Yang","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2021.154893_bb0165","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1463-1326.2006.00594.x","article-title":"Cardiovascular metabolic syndrome - an interplay of, obesity, inflammation, diabetes and coronary heart disease","volume":"9","author":"Rana","year":"2007","journal-title":"Diabetes Obes Metab"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049521001931?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049521001931?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T04:30:01Z","timestamp":1758429001000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049521001931"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":33,"alternative-id":["S0026049521001931"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2021.154893","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The presence of NAFLD influences the transition of metabolically healthy to metabolically unhealthy obesity and the ten-year cardiovascular disease risk: A population-based cohort study","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2021.154893","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"154893"}}